 | • レポートコード：QYR9ST05352 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、光線角化症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、外用薬、光線力学療法、破壊的治療に、用途別には、病院、診療所、その他にセグメント区分し、光線角化症治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・光線角化症治療薬の世界市場概要 ・光線角化症治療薬の製造コスト構成分析 ・光線角化症治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・光線角化症治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・光線角化症治療薬のセグメント分析（種類別） （外用薬、光線力学療法、破壊的治療） ・光線角化症治療薬のセグメント分析（用途別） （病院、診療所、その他） ・光線角化症治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （DUSA Pharmaceuticals、Novartis、Perrigo、LEO Pharma、Bausch Health、Taro Pharmaceutical、Galderma (Nestle)、Biofrontera、Almirall、Tolmar Pharmaceutical） ・光線角化症治療薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It’s most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck.
The global Actinic Keratosis Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Actinic Keratosis Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Actinic Keratosis Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Actinic Keratosis Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Actinic Keratosis Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
DUSA Pharmaceuticals
Novartis
Perrigo
LEO Pharma
Bausch Health
Taro Pharmaceutical
Galderma (Nestle)
Biofrontera
Almirall
Tolmar Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Topical Medications
Photodynamic Therapy
Destructive Treatment
Segment by Application
Hospitals
Clinics
Other
Table of Contents
Executive Summary
1 Industry Overview of Actinic Keratosis Therapeutics
1.1 Definition of Actinic Keratosis Therapeutics
1.2 Actinic Keratosis Therapeutics Segment by Type
1.2.1 Global Actinic Keratosis Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Topical Medications
1.2.3 Photodynamic Therapy
1.2.4 Destructive Treatment
1.3 Actinic Keratosis Therapeutics Segment by Applications
1.3.1 Global Actinic Keratosis Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Actinic Keratosis Therapeutics Overall Market
1.4.1 Global Actinic Keratosis Therapeutics Revenue (2014-2025)
1.4.2 Global Actinic Keratosis Therapeutics Production (2014-2025)
1.4.3 North America Actinic Keratosis Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Actinic Keratosis Therapeutics Status and Prospect (2014-2025)
1.4.5 China Actinic Keratosis Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Actinic Keratosis Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Actinic Keratosis Therapeutics Status and Prospect (2014-2025)
1.4.8 India Actinic Keratosis Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Actinic Keratosis Therapeutics
2.3 Manufacturing Process Analysis of Actinic Keratosis Therapeutics
2.4 Industry Chain Structure of Actinic Keratosis Therapeutics
3 Development and Manufacturing Plants Analysis of Actinic Keratosis Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Actinic Keratosis Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Actinic Keratosis Therapeutics
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Actinic Keratosis Therapeutics Production and Capacity Analysis
4.2 Actinic Keratosis Therapeutics Revenue Analysis
4.3 Actinic Keratosis Therapeutics Price Analysis
4.4 Market Concentration Degree
5 Actinic Keratosis Therapeutics Regional Market Analysis
5.1 Actinic Keratosis Therapeutics Production by Regions
5.1.1 Global Actinic Keratosis Therapeutics Production by Regions
5.1.2 Global Actinic Keratosis Therapeutics Revenue by Regions
5.2 Actinic Keratosis Therapeutics Consumption by Regions
5.3 North America Actinic Keratosis Therapeutics Market Analysis
5.3.1 North America Actinic Keratosis Therapeutics Production
5.3.2 North America Actinic Keratosis Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Actinic Keratosis Therapeutics Import and Export
5.4 Europe Actinic Keratosis Therapeutics Market Analysis
5.4.1 Europe Actinic Keratosis Therapeutics Production
5.4.2 Europe Actinic Keratosis Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Actinic Keratosis Therapeutics Import and Export
5.5 China Actinic Keratosis Therapeutics Market Analysis
5.5.1 China Actinic Keratosis Therapeutics Production
5.5.2 China Actinic Keratosis Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Actinic Keratosis Therapeutics Import and Export
5.6 Japan Actinic Keratosis Therapeutics Market Analysis
5.6.1 Japan Actinic Keratosis Therapeutics Production
5.6.2 Japan Actinic Keratosis Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Actinic Keratosis Therapeutics Import and Export
5.7 Southeast Asia Actinic Keratosis Therapeutics Market Analysis
5.7.1 Southeast Asia Actinic Keratosis Therapeutics Production
5.7.2 Southeast Asia Actinic Keratosis Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Actinic Keratosis Therapeutics Import and Export
5.8 India Actinic Keratosis Therapeutics Market Analysis
5.8.1 India Actinic Keratosis Therapeutics Production
5.8.2 India Actinic Keratosis Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Actinic Keratosis Therapeutics Import and Export
6 Actinic Keratosis Therapeutics Segment Market Analysis (by Type)
6.1 Global Actinic Keratosis Therapeutics Production by Type
6.2 Global Actinic Keratosis Therapeutics Revenue by Type
6.3 Actinic Keratosis Therapeutics Price by Type
7 Actinic Keratosis Therapeutics Segment Market Analysis (by Application)
7.1 Global Actinic Keratosis Therapeutics Consumption by Application
7.2 Global Actinic Keratosis Therapeutics Consumption Market Share by Application (2014-2019)
8 Actinic Keratosis Therapeutics Major Manufacturers Analysis
8.1 DUSA Pharmaceuticals
8.1.1 DUSA Pharmaceuticals Actinic Keratosis Therapeutics Production Sites and Area Served
8.1.2 DUSA Pharmaceuticals Product Introduction, Application and Specification
8.1.3 DUSA Pharmaceuticals Actinic Keratosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis
8.2.1 Novartis Actinic Keratosis Therapeutics Production Sites and Area Served
8.2.2 Novartis Product Introduction, Application and Specification
8.2.3 Novartis Actinic Keratosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Perrigo
8.3.1 Perrigo Actinic Keratosis Therapeutics Production Sites and Area Served
8.3.2 Perrigo Product Introduction, Application and Specification
8.3.3 Perrigo Actinic Keratosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 LEO Pharma
8.4.1 LEO Pharma Actinic Keratosis Therapeutics Production Sites and Area Served
8.4.2 LEO Pharma Product Introduction, Application and Specification
8.4.3 LEO Pharma Actinic Keratosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bausch Health
8.5.1 Bausch Health Actinic Keratosis Therapeutics Production Sites and Area Served
8.5.2 Bausch Health Product Introduction, Application and Specification
8.5.3 Bausch Health Actinic Keratosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Taro Pharmaceutical
8.6.1 Taro Pharmaceutical Actinic Keratosis Therapeutics Production Sites and Area Served
8.6.2 Taro Pharmaceutical Product Introduction, Application and Specification
8.6.3 Taro Pharmaceutical Actinic Keratosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Galderma (Nestle)
8.7.1 Galderma (Nestle) Actinic Keratosis Therapeutics Production Sites and Area Served
8.7.2 Galderma (Nestle) Product Introduction, Application and Specification
8.7.3 Galderma (Nestle) Actinic Keratosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Biofrontera
8.8.1 Biofrontera Actinic Keratosis Therapeutics Production Sites and Area Served
8.8.2 Biofrontera Product Introduction, Application and Specification
8.8.3 Biofrontera Actinic Keratosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Almirall
8.9.1 Almirall Actinic Keratosis Therapeutics Production Sites and Area Served
8.9.2 Almirall Product Introduction, Application and Specification
8.9.3 Almirall Actinic Keratosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Tolmar Pharmaceutical
8.10.1 Tolmar Pharmaceutical Actinic Keratosis Therapeutics Production Sites and Area Served
8.10.2 Tolmar Pharmaceutical Product Introduction, Application and Specification
8.10.3 Tolmar Pharmaceutical Actinic Keratosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Actinic Keratosis Therapeutics Market
9.1 Global Actinic Keratosis Therapeutics Market Trend Analysis
9.1.1 Global Actinic Keratosis Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Actinic Keratosis Therapeutics Regional Market Trend
9.2.1 North America Actinic Keratosis Therapeutics Forecast 2019-2025
9.2.2 Europe Actinic Keratosis Therapeutics Forecast 2019-2025
9.2.3 China Actinic Keratosis Therapeutics Forecast 2019-2025
9.2.4 Japan Actinic Keratosis Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Actinic Keratosis Therapeutics Forecast 2019-2025
9.2.6 India Actinic Keratosis Therapeutics Forecast 2019-2025
9.3 Actinic Keratosis Therapeutics Market Trend (Product Type)
9.4 Actinic Keratosis Therapeutics Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Actinic Keratosis Therapeutics Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Actinic Keratosis Therapeutics
Table Global Actinic Keratosis Therapeutics Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Actinic Keratosis Therapeutics Production Market Share by Types in 2018
Figure Topical Medications Product Picture
Figure Photodynamic Therapy Product Picture
Figure Destructive Treatment Product Picture
Table Global Actinic Keratosis Therapeutics Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Actinic Keratosis Therapeutics Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Figure Other
Figure Global Actinic Keratosis Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Actinic Keratosis Therapeutics Production (K Units) (2014-2025)
Figure North America Actinic Keratosis Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Actinic Keratosis Therapeutics Market Size (Million USD) (2014-2025)
Figure China Actinic Keratosis Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Actinic Keratosis Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Actinic Keratosis Therapeutics Market Size (Million USD) (2014-2025)
Figure India Actinic Keratosis Therapeutics Market Size (Million USD) (2014-2025)
Table Actinic Keratosis Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Actinic Keratosis Therapeutics in 2018
Figure Manufacturing Process Analysis of Actinic Keratosis Therapeutics
Figure Industry Chain Structure of Actinic Keratosis Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Actinic Keratosis Therapeutics Manufacturing Plants Distribution
Table Actinic Keratosis Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Actinic Keratosis Therapeutics Capacity (K Units) of Major Manufacturers (2014-2019)
Table Actinic Keratosis Therapeutics Production (K Units) of Major Manufacturers (2014-2019)
Table Actinic Keratosis Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Actinic Keratosis Therapeutics Production Share by Manufacturers in 2018
Table Actinic Keratosis Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Actinic Keratosis Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Actinic Keratosis Therapeutics Revenue Share by Manufacturers in 2018
Table Actinic Keratosis Therapeutics Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Actinic Keratosis Therapeutics Production by Regions 2014-2019 (K Units)
Table Global Actinic Keratosis Therapeutics Production Market Share by Regions 2014-2019
Figure Global Actinic Keratosis Therapeutics Production Market Share by Regions in 2018
Table Global Actinic Keratosis Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Actinic Keratosis Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Actinic Keratosis Therapeutics Revenue Market Share by Regions in 2018
Table Global Actinic Keratosis Therapeutics Consumption by Regions 2014-2019 (K Units)
Table Global Actinic Keratosis Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Actinic Keratosis Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure North America Actinic Keratosis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Actinic Keratosis Therapeutics Production, Consumption Import and Export (K Units)
Figure Europe Actinic Keratosis Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Europe Actinic Keratosis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Actinic Keratosis Therapeutics Production, Consumption Import and Export (K Units)
Figure China Actinic Keratosis Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure China Actinic Keratosis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Actinic Keratosis Therapeutics Production, Consumption Import and Export (K Units)
Figure Japan Actinic Keratosis Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Japan Actinic Keratosis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Actinic Keratosis Therapeutics Production, Consumption Import and Export (K Units)
Figure Southeast Asia Actinic Keratosis Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Actinic Keratosis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Actinic Keratosis Therapeutics Production, Consumption Import and Export (K Units)
Figure India Actinic Keratosis Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure India Actinic Keratosis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Actinic Keratosis Therapeutics Production, Consumption Import and Export (K Units)
Figure Global Consumption Actinic Keratosis Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Actinic Keratosis Therapeutics Market Share by Application (2014-2019)
Table DUSA Pharmaceuticals Actinic Keratosis Therapeutics Production Sites and Area Served
Table DUSA Pharmaceuticals Actinic Keratosis Therapeutics Product Introduction, Application and Specification
Table DUSA Pharmaceuticals Actinic Keratosis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table DUSA Pharmaceuticals Actinic Keratosis Therapeutics Production Growth Rate (2014-2019)
Table DUSA Pharmaceuticals Actinic Keratosis Therapeutics Production Market Share (2014-2019)
Figure DUSA Pharmaceuticals Actinic Keratosis Therapeutics Revenue Market Share (2014-2019)
Table DUSA Pharmaceuticals Actinic Keratosis Therapeutics Main Business and Markets Served
Table Novartis Actinic Keratosis Therapeutics Production Sites and Area Served
Table Novartis Actinic Keratosis Therapeutics Product Introduction, Application and Specification
Table Novartis Actinic Keratosis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Actinic Keratosis Therapeutics Production Growth Rate (2014-2019)
Table Novartis Actinic Keratosis Therapeutics Production Market Share (2014-2019)
Figure Novartis Actinic Keratosis Therapeutics Revenue Market Share (2014-2019)
Table Novartis Actinic Keratosis Therapeutics Main Business and Markets Served
Table Perrigo Actinic Keratosis Therapeutics Production Sites and Area Served
Table Perrigo Actinic Keratosis Therapeutics Product Introduction, Application and Specification
Table Perrigo Actinic Keratosis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Perrigo Actinic Keratosis Therapeutics Production Growth Rate (2014-2019)
Table Perrigo Actinic Keratosis Therapeutics Production Market Share (2014-2019)
Figure Perrigo Actinic Keratosis Therapeutics Revenue Market Share (2014-2019)
Table Perrigo Actinic Keratosis Therapeutics Main Business and Markets Served
Table LEO Pharma Actinic Keratosis Therapeutics Production Sites and Area Served
Table LEO Pharma Actinic Keratosis Therapeutics Product Introduction, Application and Specification
Table LEO Pharma Actinic Keratosis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table LEO Pharma Actinic Keratosis Therapeutics Production Growth Rate (2014-2019)
Table LEO Pharma Actinic Keratosis Therapeutics Production Market Share (2014-2019)
Figure LEO Pharma Actinic Keratosis Therapeutics Revenue Market Share (2014-2019)
Table LEO Pharma Actinic Keratosis Therapeutics Main Business and Markets Served
Table Bausch Health Actinic Keratosis Therapeutics Production Sites and Area Served
Table Bausch Health Actinic Keratosis Therapeutics Product Introduction, Application and Specification
Table Bausch Health Actinic Keratosis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bausch Health Actinic Keratosis Therapeutics Production Growth Rate (2014-2019)
Table Bausch Health Actinic Keratosis Therapeutics Production Market Share (2014-2019)
Figure Bausch Health Actinic Keratosis Therapeutics Revenue Market Share (2014-2019)
Table Bausch Health Actinic Keratosis Therapeutics Main Business and Markets Served
Table Taro Pharmaceutical Actinic Keratosis Therapeutics Production Sites and Area Served
Table Taro Pharmaceutical Actinic Keratosis Therapeutics Product Introduction, Application and Specification
Table Taro Pharmaceutical Actinic Keratosis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Taro Pharmaceutical Actinic Keratosis Therapeutics Production Growth Rate (2014-2019)
Table Taro Pharmaceutical Actinic Keratosis Therapeutics Production Market Share (2014-2019)
Figure Taro Pharmaceutical Actinic Keratosis Therapeutics Revenue Market Share (2014-2019)
Table Taro Pharmaceutical Actinic Keratosis Therapeutics Main Business and Markets Served
Table Galderma (Nestle) Actinic Keratosis Therapeutics Production Sites and Area Served
Table Galderma (Nestle) Actinic Keratosis Therapeutics Product Introduction, Application and Specification
Table Galderma (Nestle) Actinic Keratosis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Galderma (Nestle) Actinic Keratosis Therapeutics Production Growth Rate (2014-2019)
Table Galderma (Nestle) Actinic Keratosis Therapeutics Production Market Share (2014-2019)
Figure Galderma (Nestle) Actinic Keratosis Therapeutics Revenue Market Share (2014-2019)
Table Galderma (Nestle) Actinic Keratosis Therapeutics Main Business and Markets Served
Table Biofrontera Actinic Keratosis Therapeutics Production Sites and Area Served
Table Biofrontera Actinic Keratosis Therapeutics Product Introduction, Application and Specification
Table Biofrontera Actinic Keratosis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biofrontera Actinic Keratosis Therapeutics Production Growth Rate (2014-2019)
Table Biofrontera Actinic Keratosis Therapeutics Production Market Share (2014-2019)
Figure Biofrontera Actinic Keratosis Therapeutics Revenue Market Share (2014-2019)
Table Biofrontera Actinic Keratosis Therapeutics Main Business and Markets Served
Table Almirall Actinic Keratosis Therapeutics Production Sites and Area Served
Table Almirall Actinic Keratosis Therapeutics Product Introduction, Application and Specification
Table Almirall Actinic Keratosis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Almirall Actinic Keratosis Therapeutics Production Growth Rate (2014-2019)
Table Almirall Actinic Keratosis Therapeutics Production Market Share (2014-2019)
Figure Almirall Actinic Keratosis Therapeutics Revenue Market Share (2014-2019)
Table Almirall Actinic Keratosis Therapeutics Main Business and Markets Served
Table Tolmar Pharmaceutical Actinic Keratosis Therapeutics Production Sites and Area Served
Table Tolmar Pharmaceutical Actinic Keratosis Therapeutics Product Introduction, Application and Specification
Table Tolmar Pharmaceutical Actinic Keratosis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Tolmar Pharmaceutical Actinic Keratosis Therapeutics Production Growth Rate (2014-2019)
Table Tolmar Pharmaceutical Actinic Keratosis Therapeutics Production Market Share (2014-2019)
Figure Tolmar Pharmaceutical Actinic Keratosis Therapeutics Revenue Market Share (2014-2019)
Table Tolmar Pharmaceutical Actinic Keratosis Therapeutics Main Business and Markets Served
Figure Global Actinic Keratosis Therapeutics Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Actinic Keratosis Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Actinic Keratosis Therapeutics Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Actinic Keratosis Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Actinic Keratosis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Actinic Keratosis Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Actinic Keratosis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Actinic Keratosis Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Actinic Keratosis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Actinic Keratosis Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Actinic Keratosis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Actinic Keratosis Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Actinic Keratosis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Actinic Keratosis Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Actinic Keratosis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Actinic Keratosis Therapeutics by Type (2019-2025)
Table Global Consumption (K Units) of Actinic Keratosis Therapeutics by Application (2019-2025)
Table Actinic Keratosis Therapeutics Distributors List
Table Actinic Keratosis Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の光線角化症治療薬市場：専門的調査 Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It's most commonly found on the face, lips, ears, back of your hands, forearms, …- 基底細胞癌治療の世界市場：市場規模・現状・予測 Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening…
- アトピー性皮膚炎治療の世界市場：市場規模・現状・予測 Atopic dermatitis (AD), also called atopic eczema, is a chronic, pruritic, inflammatory skin disease arising from a complex interrelationship of environmental, immunologic, genetic, and pharmacologic factors, with a characteristic phenotype and typically distributed skin lesions.In 2018, the global …
- アトピー性皮膚炎治療の世界市場：市場規模・現状・予測 Atopic dermatitis (AD), also called atopic eczema, is a chronic, pruritic, inflammatory skin disease arising from a complex interrelationship of environmental, immunologic, genetic, and pharmacologic factors, with a characteristic phenotype and typically distributed skin lesions.In 2018, the global …
- 皮膚がん治療薬の世界市場：市場規模・現状・予測 On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the exte…